ANTI-ARF
- $282 - $580
- Product name: ANTI-ARF
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:MFCD01094377
- Synonyms:ANTI-P14;ANTI-ARF;ANTI-ADP-RIBOSYLATION FACTOR;Monoclonal Anti-p19ARF antibody produced in mouse;Anti-CGI-110;Anti-HSPC175;Anti-Ht006;Anti-SAP14
3 prices
Selected condition:
Brand
- Sigma-Aldrich
Package
- 100μG
- 25μL
- 100μL
- ManufacturerSigma-Aldrich
- Product numberHPA036194
- Product descriptionAnti-RPP14 antibody produced in rabbit Prestige Antibodies? Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
- Packaging25μL
- Price$282
- Updated2023-06-20
- Buy
- ManufacturerSigma-Aldrich
- Product numberSAB1411220
- Product descriptionAnti-S100A9 antibody produced in rabbit purified immunoglobulin, buffered aqueous solution
- Packaging100μG
- Price$524
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberHPA036194
- Product descriptionAnti-RPP14 antibody produced in rabbit Prestige Antibodies? Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
- Packaging100μL
- Price$580
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich | HPA036194 | Anti-RPP14 antibody produced in rabbit Prestige Antibodies? Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | 25μL | $282 | 2023-06-20 | Buy |
Sigma-Aldrich | SAB1411220 | Anti-S100A9 antibody produced in rabbit purified immunoglobulin, buffered aqueous solution | 100μG | $524 | 2024-03-01 | Buy |
Sigma-Aldrich | HPA036194 | Anti-RPP14 antibody produced in rabbit Prestige Antibodies? Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution | 100μL | $580 | 2024-03-01 | Buy |
Properties
storage temp. :-20°C
form :buffered aqueous solution
form :buffered aqueous solution
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|